Related Experiment Video
Updated: Dec 28, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Palliative care in hematologic malignancies: a multidisciplinary approach.
Brittany Gatta1, Thomas W LeBlanc2,3
1Department of Medicine, Division of General Internal Medicine, Duke Center for Palliative Care, Duke University, Durham, NC, USA.
Palliative care significantly improves quality of life for patients with hematologic malignancies. Integrating multidisciplinary palliative care teams addresses unmet needs and overcomes barriers in hematology, unlike in solid tumor oncology.
Area of Science:
- Hematology
- Palliative Care
- Oncology
Background:
- Palliative care enhances quality of life for patients with serious illnesses.
- Hematologic malignancy patients have complex needs often unmet by current care models.
- Integration of palliative care in hematology lags behind solid tumor oncology.
Purpose of the Study:
- To review the palliative care needs of hematologic malignancy patients.
- To demonstrate how multidisciplinary palliative care teams can improve patient care.
- To explore barriers and solutions for integrating palliative care in hematology.
Main Methods:
- Literature review of recent relevant papers.
- PubMed searches for additional relevant articles from the past 3 years.
Main Results:
- Hematologic malignancy patients present unique and significant palliative care needs.
- Multidisciplinary palliative care teams can effectively address these needs.
- Barriers to integration exist but can be overcome with thoughtful implementation.
Conclusions:
- Thoughtful integration of multidisciplinary palliative care teams is crucial for hematologic malignancy patients.
- Timely integration, tailored to specific patient needs, maximizes benefits.
- Strengthening the palliative care-hematology relationship is essential for optimal patient outcomes.
Related Concept Videos
Continuing Care
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Peripheral Artery Disease III: Interprofessional Care
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
